Levetiracetam Ratiopharm (Levetiracetam)

Levetiracetam binds to the synaptic vesicle protein SV2A, which modulates the release of neurotransmitters. This action dampens excessive neuronal firing and lowers the likelihood of seizure initiation and propagation throughout the brain.

The appropriate dose of levetiracetam is determined individually by a qualified prescriber based on the patient’s age, weight, renal function, and seizure type. Healthcare professionals adjust the regimen to achieve optimal seizure control while minimising side effects.

Safety data for levetiracetam in pregnancy and lactation are limited. It should only be used when the potential benefit justifies the potential risk to the fetus or infant, and decisions should be made in consultation with a healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with older agents such as carbamazepine or valproate, levetiracetam has a relatively simple pharmacokinetic profile, fewer drug‑enzyme interactions, and is generally well tolerated. However, individual response varies, and the choice of therapy depends on seizure type, comorbidities and patient-specific factors.

Store the tablets below 25 °C in their original container, protecting them from moisture and direct light. Keep the product out of reach of children and avoid exposure to extreme temperatures or humidity to maintain potency.

Levetiracetam Ratiopharm is taken orally, usually with or without food. Tablets should be swallowed whole with a glass of water and not chewed or crushed unless specifically instructed by a healthcare professional.

Serious adverse events include severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome, suicidal thoughts or behaviours, and blood dyscrasias like neutropenia. Patients should seek immediate medical attention if they experience rash, mood changes, or signs of infection.

Levetiracetam is contraindicated in individuals with known hypersensitivity to the drug or any of its excipients. Caution is advised for patients with severe renal impairment, active psychiatric disorders, or those taking interacting anticonvulsants without appropriate monitoring.